RFK Jr. continues serving as HHS Secretary with sustained White House support, including recent joint appearances and policy alignment on Make America Healthy Again priorities such as vaccine schedule revisions, agency reorganizations, and staffing shifts toward political appointees. Leadership changes at HHS, including elevated roles for key aides and departures of deputies, reflect ongoing internal restructuring rather than any transition away from Kennedy. Federal court rulings have blocked elements of his vaccine advisory committee actions and immunization recommendations, prompting appeals and internal deliberations ahead of midterms, yet these legal and political pressures have not altered administration backing or prompted public signals of removal. Trader consensus favoring his continued tenure through year-end reflects this pattern of active engagement and institutional continuity.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено$24,839 Обс.
$24,839 Обс.
$24,839 Обс.
$24,839 Обс.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Ринок відкрито: Mar 19, 2026, 2:02 PM ET
Вирішувач
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Вирішувач
0x65070BE91...RFK Jr. continues serving as HHS Secretary with sustained White House support, including recent joint appearances and policy alignment on Make America Healthy Again priorities such as vaccine schedule revisions, agency reorganizations, and staffing shifts toward political appointees. Leadership changes at HHS, including elevated roles for key aides and departures of deputies, reflect ongoing internal restructuring rather than any transition away from Kennedy. Federal court rulings have blocked elements of his vaccine advisory committee actions and immunization recommendations, prompting appeals and internal deliberations ahead of midterms, yet these legal and political pressures have not altered administration backing or prompted public signals of removal. Trader consensus favoring his continued tenure through year-end reflects this pattern of active engagement and institutional continuity.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено


Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання